A bill to amend the Federal Food, Drug, and Cosmetic Act and the Defense Production Act of 1950 to prohibit the Federal Government from limiting State access to key therapies, such as monoclonal antibodies, and from prioritizing Federal contracts over State contracts relating to purchasing supplies to combat the COVID-19 pandemic.
The official print number for this legislation is 117_S_3440.
This legislation was initiated in the Senate.
The process officially started on 2022-01-04.
Key points include:
The current status is Expired.
The full official text is available at: View full text
The primary sponsor is Sen. Cruz, Ted [R-TX].
The latest detailed status is: Introduced in Senate
Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.